• Kyodo, JIJI

  • SHARE

Toshiba Corp. has developed technology to detect 13 types of cancer from a single drop of blood with 99 percent accuracy, the company announced Monday.

Toshiba developed the diagnosis method together with the National Cancer Center Research Institute and Tokyo Medical University, and hopes to commercialize it in “several years” after starting a trial next year.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)